This was a prospective observational study that included 22 emergency departments (EDs) in the Pediatric Emergency Care Applied Research Network (PECARN). A convenience sample of infants aged 60 days or younger were evaluated for fever (rectal temperatures >38° C documented in the ED, home, or clinic). Those who underwent laboratory evaluations that included at least 1 blood culture were enrolled. Febrile infants presenting to any of the 22 EDs when study research staff members were available were screened for study eligibility. The parents or guardians of eligible infants were approached, and their infants were enrolled upon receiving written informed consent. The study was approved by the institutional review boards at all sites. For this preliminary analysis, a random sample of enrolled infants was selected (described below).
The goal was to focus on infants who posed diagnostic quandaries; therefore, infants with clinical sepsis, prematurity, significant comorbidities, focal bacterial infections (except otitis media), and those already receiving antibiotics were excluded. Laboratory evaluations, aside from blood cultures and blood draws for RNA biosignatures, were performed at the treating physician’s discretion and typically included white blood cell counts, urinalyses and urine cultures, and CSF analyses and cultures. Based on culture results, febrile infants were assigned either to the bacterial infection group (bacteremia, UTI, bacterial meningitis) or to the without-bacterial-infection group.